Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]‐FP‐CIT SPECT imaging: The [123I]‐FP‐CIT study group

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Movement Disorders

• Publication date

  2000-05-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1002/1531-8257(200005)15:3<503::AID-MDS1013>3.0.CO;2-VPMID 28470733
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Practical benefit of [123I]FP-CIT SPET in the demonstration of the dopaminergic deficit in Parkinson's disease

  2005cited by this paper
• [123I]β-CIT and SPECT in essential tremor and Parkinson's disease

  1998cited by this paper
• Differential distribution of striatal [123I]β-CIT in Parkinson’s disease and progressive supranuclear palsy, evaluated with single-photon emission tomography

  1998cited by this paper
• [123I]beta-CIT and SPECT in essential tremor and Parkinson's disease.

  1998cited by this paper
• Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.

  1998cited by this paper
• Iodine-123-β-CIT and Iodine-123-FPCIT SPECT Measurement of Dopamine Transporters in Healthy Subjects and Parkinson's Patients

  1998cited by this paper
• Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease.

  1998cited by this paper
• Measurement of the dopaminergic degeneration in Parkinson’s disease with [123I]β-CIT and SPECT

  1997cited by this paper
• The dopamine transporter: A crucial component regulating dopamine transmission

  1997cited by this paper
• Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transporters

  1997cited by this paper
• [123I]FP‐CIT binds to the dopamine transporter as assessed by biodistribution studies in rats and SPECT studies in MPTP‐lesioned monkeys

  1997cited by this paper
• [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease.

  1997cited by this paper
• Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease.

  1997cited by this paper
• Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)

  1996cited by this paper
• SPECT imaging of dopamine transporters in human brain with iodine-123-fluoroalkyl analogs of beta-CIT.

  1996cited by this paper
• Fortnightly Review: Parkinsonism—recognition and differential diagnosis

  1995cited by this paper
• Graphical, Kinetic, and Equilibrium Analyses of in vivo [123I]β-CIT Binding to Dopamine Transporters in Healthy Human Subjects

  1994cited by this paper
• Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data.

  1994cited by this paper
• Functional imaging in relation to parkinsonian syndromes.

  1993cited by this paper
• Neurotransmitter transporters: recent progress.

  1993cited by this paper
• Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

  1992cited by this paper
• What features improve the accuracy of clinical diagnosis in Parkinson's disease

  1992cited by this paper
• Apomorphine test for dopaminergic responsiveness in patients with previously untreated Parkinson's disease.

  1992cited by this paper
• Isolated tremor and disruption of the nigrostriatal dopaminergic system

  1992cited by this paper
• Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's‐diseased striatum

  1991cited by this paper
• Challenge tests to predict the dopaminergic response in untreated Parkinson's disease

  1991cited by this paper
• The apomorphine test in parkinsonian syndromes.

  1991cited by this paper
• Clinicopathologic observations in essential tremor

  1991cited by this paper
• The Dopamine Transporter Is Absent in Parkinsonian Putamen and Reduced in the Caudate Nucleus

  1991cited by this paper
• Differing patterns of striatal 18F‐dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy

  1990cited by this paper
• Apomorphine test to predict dopaminergic responsiveness in parkinsonian syndromes.

  1990cited by this paper
• Research diagnostic criteria for Parkinson's disease.

  1990cited by this paper
• The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

  1988cited by this paper
• Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale

  1987cited by this paper
• Essential tremor.

  1983cited by this paper
• Clinical manifestations of essential tremor

  1972cited by this paper
• Parkinsonism

  1967cited by this paper
• OBSERVATIONS ON ESSENTIAL TREMOR

  1962cited by this paper

• Toward Harmonizing Quantification of Dopamine Neuron Imaging Biomarkers in Parkinson's Disease: The Centamine Scale.

  2026cites this paper
• Prediction of 123I-FP-CIT SPECT Results from First Acquired Projections Using Artificial Intelligence

  2025cites this paper
• Semiautomatic Quantification of 99mTc‐TRODAT‐1 SPECT Images in Patients With Idiopathic Parkinson's Disease

  2025cites this paper
• Unveiling the Cutting Edge: Recent Developments in α-Synuclein Nano-biosensor Technology for Precision Diagnosis of Parkinson’s Disease

  2025cites this paper
• Proposed biological definitions of Parkinson's disease confuse understanding without delivering meaningful advances

  2025cites this paper
• Late‐life parkinsonism in bipolar disorder

  2025cites this paper
• Comparison of visual interpretation of [I-123] FP-CIT SPECT scans versus reference-based quantitative analysis utilizing a Japanese normal database

  2025cites this paper
• Gait Improvement Following CSF Tap Test in NPH Patients With and Without Striatal Dopaminergic Deficit: A Preliminary Study.

  2025cites this paper
• Exploring Dynamic Alpha Band Connectivity in Parkinson’s Disease: A Novel Approach to Postural Control Assessment Using the BioVRSea Paradigm

  2025cites this paper
• Parkinsonism in bipolar disorder: a clinical-neuroimaging study

  2024cites this paper
• Convention vs. Innovation II: Skin biopsy for synuclein inclusions will replace dopamine transporter imaging for Parkinson disease diagnosis.

  2024cites this paper
• Diagnostic Sensitivity and Symptomatic Relevance of Dopamine Transporter Imaging and Myocardial Sympathetic Scintigraphy in Patients with Dementia with Lewy Bodies

  2024cites this paper
• Robustness of radiomic features in 123I-ioflupane-dopamine transporter single-photon emission computer tomography scan

  2024cites this paper
• Relevance of 123I-FP-CIT SPECT prescriptions for the diagnosis of parkinsonian syndromes

  2024cites this paper
• Accurate Automated Quantification of Dopamine Transporter PET Without MRI Using Deep Learning-based Spatial Normalization

  2024cites this paper
• Dopaminergic PET to SPECT domain adaptation: a cycle GAN translation approach

  2024cites this paper
• Neuropathologic Validation and Diagnostic Accuracy of Presynaptic Dopaminergic Imaging in the Diagnosis of Parkinsonism.

  2024cites this paper
• Accurate early detection of Parkinson's disease from SPECT imaging through Convolutional Neural Networks

  2024cites this paper
• Distinguishing essential tremor from Parkinson’s disease: clinical and experimental tools

  2024cites this paper
• PET, SPECT, and MRI imaging for evaluation of Parkinson's disease.

  2024cites this paper
• Exploration de l’encéphale en médecine nucléaire : techniques, résultats normaux et principales applications en clinique

  2023cites this paper
• Subtle changes in central dopaminergic tone underlie bradykinesia in essential tremor

  2023cites this paper
• Association between longitudinal changes in striatal dopamine transporter uptake and clinical features of dementia with Lewy bodies

  2023cites this paper
• Neuroimaging Techniques in Differentiating Parkinson’s Disease from Drug-Induced Parkinsonism: A Comprehensive Review

  2023cites this paper
• Brain Noradrenergic Innervation Supports the Development of Parkinson’s Tremor: A Study in a Reserpinized Rat Model

  2023influential citation
• DaTSCAN® dilution with 0.9% NaCl - A stability evaluation.

  2023cites this paper
• Prediction of Parkinson's disease pathogenic variants using hybrid Machine learning systems and radiomic features.

  2023cites this paper
• Dopamine transporter single photon emission computed tomography (DaT-SPECT) use in the diagnosis and clinical management of parkinsonism: an 8-year retrospective study

  2023cites this paper
• Verification of optimal conditions for the scattering correction of ^123I-FP-CIT SPECT on a single-photon emission tomography system with a two-detector whole-body cadmium–zinc–telluride semiconductor detector

  2023cites this paper
• TremorSoft: An decision support application for differential diagnosis between Parkinson's disease and essential tremor

  2023cites this paper
• Diagnostic Uncertainties in Tremor

  2023cites this paper
• How should we be using biomarkers in trials of disease modification in Parkinson’s disease?

  2023cites this paper
• Dopamine transporter SPECT imaging in Parkinson’s disease and atypical Parkinsonism: a study of 137 patients

  2023cites this paper
• Diagnostic accuracy of 18F-FP-CIT PET for clinically uncertain Parkinsonian syndrome

  2023cites this paper
• Safety, biodistribution and radiation dosimetry of [123I]ioflupane in healthy Chinese volunteers

  2023cites this paper
• Specific Binding Ratio Estimation of [123I]-FP-CIT SPECT Using Frontal Projection Image and Machine Learning

  2023cites this paper
• Structural brain differences in essential tremor and Parkinson's disease deep brain stimulation patients.

  2023cites this paper
• A systematic review of the potential effects of medications and drugs of abuse on dopamine transporter imaging using [123I]I-FP-CIT SPECT in routine practice

  2023cites this paper
• The role of laboratory investigations in the classification of tremors

  2023cites this paper
• Predictability of inter-regional cerebral perfusion similarity on dopamine responsiveness and the moderation role of cognition in PD patients

  2023cites this paper
• The clinical diagnosis of Parkinson's disease

  2023cites this paper
• Different z-score cut-offs for striatal binding ratio (SBR) of DaT SPECT are needed to support the diagnosis of Parkinson’s Disease (PD) and dementia with Lewy bodies (DLB)

  2022cites this paper
• Update diagnostische Bildgebung des dopaminergen Systems

  2022cites this paper
• Comparison of [18F]-FDOPA PET and [123I]-FP-CIT SPECT acquired in clinical practice for assessing nigrostriatal degeneration in patients with a clinically uncertain parkinsonian syndrome

  2022cites this paper
• Differences in Striatal Metabolism in [18F]FDG PET in Parkinson’s Disease and Atypical Parkinsonism

  2022cites this paper
• Deep phenotyping for precision medicine in Parkinson's disease

  2022cites this paper
• Création d’une base de données locale des valeurs de référence pour l’analyse quantitative de la TEMP au 123I-FP-CIT (DaTSCAN®) : une approche pratique à travers l’analyse rétrospective des examens effectués

  2022cites this paper
• Generation of Digital Brain Phantom for Machine Learning Application of Dopamine Transporter Radionuclide Imaging

  2022cites this paper
• Dopaminergic Correlates of Regional Cerebral Blood Flow in Parkinsonian Disorders

  2022cites this paper
• Diagnosis and Treatment of Tremor in Parkinson’s Disease Using Mechanical Devices

  2022cites this paper
• Distinguishing Lewy Body Dementia from Alzheimer's Disease using Machine Learning on Heterogeneous Data: A Feasibility Study

  2022cites this paper
• Characterization of Parkinson's Disease Subtypes and Related Attributes

  2022cites this paper
• A prospective multi-centre study of susceptibility map-weighted MRI for the diagnosis of neurodegenerative parkinsonism

  2022cites this paper
• Computer-Aided Classification Framework of Parkinsonian Disorders Using 11C-CFT PET Imaging

  2022cites this paper
• Blood SSR1: A Possible Biomarker for Early Prediction of Parkinson’s Disease

  2022cites this paper
• Evaluation of Brain SPECT with 99mTc-TRODAT-1 in the Differential Diagnosis of Parkinsonism

  2022influential citation
• Bidirectional Correlations Between Dopaminergic Function and Motivation in Parkinson’s Disease

  2021cites this paper
• Multiparametric magnetic resonance imaging and positron emission tomography findings in neurodegenerative diseases: Current status and future directions

  2021cites this paper
• Dopaminergic imaging in degenerative parkinsonisms, an established clinical diagnostic tool

  2021cites this paper
• Effect of Cerebrospinal Fluid Area Mask Correction on 123I-FP-CIT SPECT Images in Idiopathic Normal Pressure Hydrocephalus

  2021influential citation
• Ordinal classification of the affectation level of 3D-images in Parkinson diseases

  2021cites this paper
• Dopamine transporter (DAT) imaging in Parkinson’s disease and related disorders

  2021cites this paper
• The Pathophysiology and Treatment of Essential Tremor: The Role of Adenosine and Dopamine Receptors in Animal Models

  2021cites this paper
• Dopamine Transporter Imaging, Current Status of a Potential Biomarker: A Comprehensive Review

  2021cites this paper
• Effect of cerebrospinal fluid area mask correction on 123I-FP-CIT SPECT images in idiopathic normal pressure hydrocephalus

  2021cites this paper
• The Molecular Neuroimaging of Tremor

  2021cites this paper
• Deep Brain Stimulation for Tremor: Update on Long-Term Outcomes, Target Considerations and Future Directions

  2021cites this paper
• Diffusion tensor imaging findings of patients with parkinson's disease refractory to medical treatment

  2021cites this paper
• Differences in cause and 12-month follow-up outcome of parkinsonian symptoms in depressed older adults treated with antipsychotics: a case series

  2021cites this paper
• High Prevalence of Early Parkinson's Disease in Patients With Subtle Parkinsonian Signs

  2021cites this paper
• Imaging the Pathophysiology of Essential Tremor—A Systematic Review

  2021cites this paper
• A deep explainable artificial intelligent framework for neurological disorders discrimination

  2021cites this paper
• Clinical utility of DaTscan in patients with suspected Parkinsonian syndrome: a systematic review and meta-analysis

  2021cites this paper
• Diagnostic accuracy of dual-phase 18F-FP-CIT PET imaging for detection and differential diagnosis of Parkinsonism

  2021cites this paper
• Accuracy of Cardiac Innervation Scintigraphy for Mild Cognitive Impairment With Lewy Bodies

  2021cites this paper
• Genetic Architecture and Molecular, Imaging and Prodromic Markers in Dementia with Lewy Bodies: State of the Art, Opportunities and Challenges

  2021cites this paper
• Accuracy of dopaminergic imaging as a biomarker for mild cognitive impairment with Lewy bodies

  2020cites this paper
• Late onset depression: dopaminergic deficit and clinical features of prodromal Parkinson’s disease: a cross-sectional study

  2020cites this paper
• Apathy and Anxiety in De Novo Parkinson's Disease Predict the Severity of Motor Complications

  2020cites this paper
• Systematic clinical approach for diagnosing upper limb tremor

  2020cites this paper
• Isolated head tremor: A DAT-SPECT and somatosensory temporal discrimination study.

  2020cites this paper
• [123I]FP-CIT SPECT in Clinically Uncertain Parkinsonism Predicts Survival: A Data-Driven Analysis

  2020cites this paper
• Managing Essential Tremor

  2020cites this paper
• SPECT in der Diagnostik von Parkinson-Syndromen

  2020cites this paper
• Impact of Collimator on DaT-SPECT Imaging: Monte Carlo Simulation Study

  2020cites this paper
• Essential Tremor as a “Waste Basket” Diagnosis: Diagnosing Essential Tremor Remains a Challenge

  2020cites this paper
• SPECT and PET of the Brain

  2020cites this paper
• Idiopathisches Parkinson-Syndrom (IPS)

  2020cites this paper
• Mild cognitive impairment with Lewy bodies: neuropsychiatric supportive symptoms and cognitive profile

  2020cites this paper
• The Role of Imaging Modalities in the Diagnosis of Parkinsons disease

  2020cites this paper
• Nigrosome 1 imaging: technical considerations and clinical applications.

  2019cites this paper
• Quantitative Research of 11C-CFT and 18F-FDG PET in Parkinson’s Disease: A Pilot Study With NeuroQ Software

  2019cites this paper
• Visual and Semiquantitative Accuracy in Clinical Baseline 123I-Ioflupane SPECT/CT Imaging

  2019cites this paper
• Prevalence and severity of symptoms suggestive of gastroparesis in prodromal dementia with Lewy bodies

  2019cites this paper
• Edinburgh Research Explorer -synuclein RT-QuIC in cerebrospinal fluid of LRRK2 linked Parkinson’s disease

  2019cites this paper
• Performance of compressed sensing-based iterative reconstruction for single-photon emission computed tomography from undersampled projection data: a simulation study in 123I-N-&ohgr;-fluoropropyl-2&bgr;-carbomethoxy-3&bgr;-(4-iodophenyl)nortropane imaging

  2019cites this paper
• Three Dimensional Analysis of SPECT Images for Diagnosing Early Parkinson's Disease using Radial Basis Function Kernel - Extreme Learning Machine.

  2019cites this paper
• AdvAnces in neurodegenerAtive And psychiAtric imAging speciAl feAture: review Article nigrosome 1 imaging: technical considerations and clinical applications

  2019cites this paper
• Neuroimaging in Dementia

  2019cites this paper
• Late onset depression: Association with clinical and imaging indicators of prodromal Parkinson’s disease

  2019cites this paper